Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. News Desk 2018 Message Board

AssistRx to Offer its iAssist Solution on the Acce

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 617763
(Total Views: 236)
Posted On: 02/21/2017 11:30:03 AM
Avatar
Posted By: News Desk 2018
AssistRx to Offer its iAssist Solution on the Accenture Intelligent Patient Service Exchange

ORLANDO, FL--(Marketwired - Feb 21, 2017) - AssistRx (ARx), the leading enterprise technology platform focused on specialty and highly managed medications, today announced it will make available its iAssist solution on the Accenture Intelligent Patient Service Exchange, a digital marketplace of third-party technology solutions available to life sciences companies to enhance patient support and improve the overall patient treatment experience.


The Accenture Intelligent Patient Service Exchange removes the time and cost needed to develop custom, digital patient-centric solutions by offering pre-built, plug-and-play technology connections that enable life sciences companies to integrate patient services more quickly and at a lower cost than previously possible.


Life sciences companies using the Intelligent Patient Service Exchange can leverage iAssist Workflows to onboard patients to a specialty or highly managed treatment by simplifying patient access and accelerating time-to-therapy to improve patient adherence, compliance, and outcomes.


"Today's technology solutions should simplify what are often complicated paper processes in healthcare. We streamline the prescribing process for specialty and highly managed drugs, therefore simplifying patient access, accelerating time-to-therapy, and improving patient care," said Edward Hensley, AssistRx's Chief Commercial Officer. "As part of the Accenture Intelligent Patient Service Exchange, our solution is further validated as a specialty prescribing technology platform."


The Intelligent Patient Service Exchange is embedded into the Accenture Intelligent Patient Platform -- a suite of integrated analytics-driven solutions that help life sciences companies design, deliver, measure and refine more precise support programs for patient segments.


For more information about AssistRx, visit www.assistrx.com. To learn more about Accenture's new digital marketplace of third-party technology solutions available to life sciences companies, visit Accenture Intelligent Patient Service Exchange. Accenture (NYSE: ACN) is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations.


About AssistRx


AssistRx's mission is to connect the patient-centric healthcare team through integrated technology solutions. The AssistRx Platform is a HIPAA compliant, secure, cloud-based platform that allows for the configuration of patient access workflows through its flagship product, iAssist, with acceleration services tailored to the business and therapy needs of specific drugs, and the patients that take those drugs. Using iAssist has proven to accelerate time-to-therapy by reducing the time it takes for patients to get their medications by 45%. AssistRx has built upon the success of the Platform and iAssist with a reporting and analytic platform focused on specialty and highly-managed drug therapies, eInformatix. For additional information, visit www.assistrx.com.



Media Contacts:


Caroline Congdon

Uproar PR for AssistRx

(321) 236-0102
Email Contact



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us